Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000004

Chief Executive Officer acquired 31,797 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hackman Jeffrey S. Chief Executive Officer 2026-03-31 Option exercise +16,695 45,405 D
Hackman Jeffrey S. Chief Executive Officer 2026-03-31 Option exercise +1,159 46,564 D
Hackman Jeffrey S. Chief Executive Officer 2026-03-28 Option exercise +13,943 60,507 D
Derivatives
Hackman Jeffrey S. Chief Executive Officer 2026-03-31 Grant or award · Stock Options +200,000 $5.77 $1,154,000 725,000 D
Loading xslF345X06/form4-04022026_040412.xml…